Inovio Pharmaceuticals (INO) Stock: Gaining on Study Dosing News

By |July 26th, 2016|

Inovio Pharmaceuticals (NASDAQ: INO)

Inovio Pharmaceuticals is having an incredible day in the market today, and for good reason. The company announced that it is moving forward with a very important Phase 1 after determining dosing clinical trial. Today, we’ll talk about the clinical trial, how the stock reacted to the news, and what we […]